Plasma levels and urinary recovery of Hct were determined in seven healthy male volunteers. 75 mg Hct were administered as a tablet in a randomised fashion with or without phenytoin pretreatment (300 mg/d). Bioavailability of Hct showed considerable intra- and interindividual variation (32--87% and 42--77% respectively), but phenytoin did not influence the disposition parameters of the diuretic.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01721218DOI Listing

Publication Analysis

Top Keywords

disposition hydrochlorothiazide
4
hct
4
hydrochlorothiazide hct
4
hct phenytoin
4
phenytoin treatment
4
treatment plasma
4
plasma levels
4
levels urinary
4
urinary recovery
4
recovery hct
4

Similar Publications

Article Synopsis
  • This study compares the effects of two mTOR inhibitors, rapamycin and PP242, on hypertension and kidney function in salt-sensitive rats.
  • While rapamycin reduced hypertension and kidney inflammation, only PP242 completely prevented hypertension and improved kidney health, showing significant natriuretic effects.
  • The research identified that PP242's natriuretic effect primarily results from inhibiting the Na-Cl cotransporter and reducing Na channel activity, suggesting it may be a better therapeutic option for managing blood pressure and kidney injury in salt-sensitive individuals.
View Article and Find Full Text PDF
Article Synopsis
  • Organic anions (OAs) are negatively charged compounds, like drugs and toxicants, that are transported by specific proteins called organic anion transporters (OATs), with human OAT4 being present in kidney cells.
  • This study investigates the functional similarities between human OAT4 and mouse Oat5, using CHO cells to compare their ability to transport ochratoxin A (OTA).
  • Results showed that OAT4 and Oat5 have similar transport kinetics and selectivity for OTA, suggesting they act as functional equivalents despite being from different species, which is important for choosing animal models in renal drug studies.
View Article and Find Full Text PDF

Cardiovascular diseases such as hypertension and cardiac failure in South African children and adolescents are effectively managed long term, using a combination treatment of captopril and hydrochlorothiazide. The majority of commercially available pharmaceutical products are designed for adult patients and require extemporaneous manipulation, prior to administration to paediatric patients. There is a need to develop an age appropriate microparticulate dosing technology that is easy to swallow, dose and alter doses whilst overcoming the pharmacokinetic challenges of short half-life and biphasic pharmacokinetic disposition exhibited by hydrochlorothiazide and captopril.

View Article and Find Full Text PDF

Study Objective: Lack of blood pressure control is often seen in hypertensive patients concomitantly taking antituberculosis medications due to the complex drug-drug interactions between rifampin and antihypertensive drugs. Therefore, it is of clinical importance to understand the underlying mechanisms of these interactions to help formulate recommendations on the use of antihypertensive drugs in patients taking these medications concomitantly. Our objective was to assess the reliability of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to predict potential interactions between rifampin and antihypertensive drugs and thus provide recommendations on the choice of antihypertensive drugs in patients receiving rifampin.

View Article and Find Full Text PDF
Article Synopsis
  • Hydrochlorothiazide (HCTZ) is a commonly used diuretic for treating high blood pressure, primarily eliminated from the body by the kidneys, but the exact processes remain unclear.
  • Research using renal transporter proteins shows that HCTZ interacts significantly with organic cation and anion transporters, especially hOAT1 and hOAT3, which are crucial for its uptake.
  • The study reveals that while HCTZ is a strong substrate for these transporters, it doesn't inhibit them clinically, suggesting that other drugs affecting hOAT1 and hOAT3 could impact how HCTZ is processed in the body.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!